Company Overview

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

  • Name

    The Coca-Cola Company

  • CEO

    Mr. James Robert B. Quincey

  • Website

    www.coca-colacompany.com

  • Sector

    Beverages

  • Year Founded

    1886

Profile

  • Market Cap

    $306.35B

  • EV

    $333.97B

  • Shares Out

    4,309.87M

  • Revenue

    $46.47B

  • Employees

    79,100

Margins

  • Gross

    60.53%

  • EBITDA

    32.08%

  • Operating

    29.73%

  • Pre-Tax

    27.8%

  • Net

    22.92%

  • FCF

    19.49%

Returns (5Yr Avg)

  • ROA

    10.16%

  • ROTA

    85.5%

  • ROE

    40.3%

  • ROCE

    16.76%

  • ROIC

    12.29%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $71.05

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $19B

  • Net Debt

    $26.06B

  • Debt/Equity

    1.64

  • EBIT/Interest

    8.74

Growth (CAGR)

  • Rev 3Yr

    8.47%

  • Rev 5Yr

    5.67%

  • Rev 10Yr

    0.05%

  • Dil EPS 3Yr

    9.56%

  • Dil EPS 5Yr

    8.44%

  • Dil EPS 10Yr

    2.78%

  • Rev Fwd 2Yr

    2.74%

  • EBITDA Fwd 2Yr

    5.95%

  • EPS Fwd 2Yr

    6.26%

  • EPS LT Growth Est

    6.01%

Dividends

  • Yield

  • Payout

    76.59%

  • DPS

    $1.89

  • DPS Growth 3Yr

    4.42%

  • DPS Growth 5Yr

    3.65%

  • DPS Growth 10Yr

    4.91%

  • DPS Growth Fwd 2Yr

    5%

NYSE:KO